Cargando…

RELATIONSHIP BETWEEN SARS-COV-2 VIRAL LOAD, ANTIGEN POSITIVITY AND INFECTIOUS TITER

INTRO: Performance of SARS-CoV-2 antigen tests is described relative to RT-PCR cycle threshold (Ct) values. However, Ct values may not be consistent between tests from different manufacturers, or even between runs. Here we correlate the Roche Elecsys SARS-CoV-2 Antigen assay results to a quantitativ...

Descripción completa

Detalles Bibliográficos
Autores principales: Germuskova, Z., Strobl, M., Mock, T., Hortsch, S., Wildum, S., Bauer, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186914/
http://dx.doi.org/10.1016/j.ijid.2023.04.296
_version_ 1785042649181323264
author Germuskova, Z.
Strobl, M.
Mock, T.
Hortsch, S.
Wildum, S.
Bauer, R.
author_facet Germuskova, Z.
Strobl, M.
Mock, T.
Hortsch, S.
Wildum, S.
Bauer, R.
author_sort Germuskova, Z.
collection PubMed
description INTRO: Performance of SARS-CoV-2 antigen tests is described relative to RT-PCR cycle threshold (Ct) values. However, Ct values may not be consistent between tests from different manufacturers, or even between runs. Here we correlate the Roche Elecsys SARS-CoV-2 Antigen assay results to a quantitative RT-PCR readout as a more reproducible measure of viral load. Additionally, we look at the relationship between the antigen test results, viral load and infectious titer. METHODS: Longitudinal nasopharyngeal swab samples from patients (N=452) with severe Covid-19 pneumonia collected between 03 April and 28 May 2020 in a randomized, double-blind, placebo controlled, multicenter study to evaluate the safety and efficacy of Tocilizumab (COVACTA), were assessed for SARS-CoV-2 viral load (RNA copies/ mL) and a qualitative and semi-quantitative readout of Elecsys SARS-CoV-2 Antigen assay. Viral culture experiments were performed to determine the infectious titer (TCID50/ mL) in a subset of samples. Agreement analysis was performed to compare the results of the assays. Please note that the current intended use of Elecsys SARS-CoV-2 Antigen assay is the qualitative detection of SARS-CoV-2 antigen. FINDINGS: We observed high negative percent agreement between the Elecsys SARS-CoV-2 Antigen assay results and the RT-PCR results, while the positive percent agreement was only high in samples exceeding a certain viral load and at earlier time points from symptom onset. Infectious titer values and both the antigen assay semi-quantitative readout and the quantitative RT-PCR results correlated well. Positive percent agreement of RT-PCR and antigen results in relation to infectious titer was very high in both cases, while negative percent agreement was moderate to low. CONCLUSION: These data show that in patients with high viral load the Elecsys SARS-CoV-2 Antigen assay correlates well qualitatively and quantitatively with the presence of SARS-CoV-2 RNA and infectious virus as determined by RT-PCR and viral culture, respectively.
format Online
Article
Text
id pubmed-10186914
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-101869142023-05-16 RELATIONSHIP BETWEEN SARS-COV-2 VIRAL LOAD, ANTIGEN POSITIVITY AND INFECTIOUS TITER Germuskova, Z. Strobl, M. Mock, T. Hortsch, S. Wildum, S. Bauer, R. Int J Infect Dis Article INTRO: Performance of SARS-CoV-2 antigen tests is described relative to RT-PCR cycle threshold (Ct) values. However, Ct values may not be consistent between tests from different manufacturers, or even between runs. Here we correlate the Roche Elecsys SARS-CoV-2 Antigen assay results to a quantitative RT-PCR readout as a more reproducible measure of viral load. Additionally, we look at the relationship between the antigen test results, viral load and infectious titer. METHODS: Longitudinal nasopharyngeal swab samples from patients (N=452) with severe Covid-19 pneumonia collected between 03 April and 28 May 2020 in a randomized, double-blind, placebo controlled, multicenter study to evaluate the safety and efficacy of Tocilizumab (COVACTA), were assessed for SARS-CoV-2 viral load (RNA copies/ mL) and a qualitative and semi-quantitative readout of Elecsys SARS-CoV-2 Antigen assay. Viral culture experiments were performed to determine the infectious titer (TCID50/ mL) in a subset of samples. Agreement analysis was performed to compare the results of the assays. Please note that the current intended use of Elecsys SARS-CoV-2 Antigen assay is the qualitative detection of SARS-CoV-2 antigen. FINDINGS: We observed high negative percent agreement between the Elecsys SARS-CoV-2 Antigen assay results and the RT-PCR results, while the positive percent agreement was only high in samples exceeding a certain viral load and at earlier time points from symptom onset. Infectious titer values and both the antigen assay semi-quantitative readout and the quantitative RT-PCR results correlated well. Positive percent agreement of RT-PCR and antigen results in relation to infectious titer was very high in both cases, while negative percent agreement was moderate to low. CONCLUSION: These data show that in patients with high viral load the Elecsys SARS-CoV-2 Antigen assay correlates well qualitatively and quantitatively with the presence of SARS-CoV-2 RNA and infectious virus as determined by RT-PCR and viral culture, respectively. Published by Elsevier Ltd. 2023-05 2023-05-16 /pmc/articles/PMC10186914/ http://dx.doi.org/10.1016/j.ijid.2023.04.296 Text en Copyright © 2023 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Germuskova, Z.
Strobl, M.
Mock, T.
Hortsch, S.
Wildum, S.
Bauer, R.
RELATIONSHIP BETWEEN SARS-COV-2 VIRAL LOAD, ANTIGEN POSITIVITY AND INFECTIOUS TITER
title RELATIONSHIP BETWEEN SARS-COV-2 VIRAL LOAD, ANTIGEN POSITIVITY AND INFECTIOUS TITER
title_full RELATIONSHIP BETWEEN SARS-COV-2 VIRAL LOAD, ANTIGEN POSITIVITY AND INFECTIOUS TITER
title_fullStr RELATIONSHIP BETWEEN SARS-COV-2 VIRAL LOAD, ANTIGEN POSITIVITY AND INFECTIOUS TITER
title_full_unstemmed RELATIONSHIP BETWEEN SARS-COV-2 VIRAL LOAD, ANTIGEN POSITIVITY AND INFECTIOUS TITER
title_short RELATIONSHIP BETWEEN SARS-COV-2 VIRAL LOAD, ANTIGEN POSITIVITY AND INFECTIOUS TITER
title_sort relationship between sars-cov-2 viral load, antigen positivity and infectious titer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186914/
http://dx.doi.org/10.1016/j.ijid.2023.04.296
work_keys_str_mv AT germuskovaz relationshipbetweensarscov2viralloadantigenpositivityandinfectioustiter
AT stroblm relationshipbetweensarscov2viralloadantigenpositivityandinfectioustiter
AT mockt relationshipbetweensarscov2viralloadantigenpositivityandinfectioustiter
AT hortschs relationshipbetweensarscov2viralloadantigenpositivityandinfectioustiter
AT wildums relationshipbetweensarscov2viralloadantigenpositivityandinfectioustiter
AT bauerr relationshipbetweensarscov2viralloadantigenpositivityandinfectioustiter